Skip to main content

ORIGINAL RESEARCH article

Front. Med.

Sec. Geriatric Medicine

Volume 12 - 2025 | doi: 10.3389/fmed.2025.1483266

This article is part of the Research Topic Clinical Management of Older Persons with Cancer: Current Status and Future Directions View all 7 articles

Developing a model for predicting suicide risk among prostate cancer survivors

Provisionally accepted
Jie Yang Jie Yang ming Hai Liu ming Hai Liu Xiang Qu Xiang Qu Fan jiang Fan jiang wei Jie Hao wei Jie Hao rong Pei Rong rong Pei Rong jie An Zheng jie An Zheng *Peng Ning Peng Ning *
  • Baoji Gaoxin Hospital, Baoji, China

The final, formatted version of the article will be published soon.

    Objective: Given the significantly higher suicide risk among cancer survivors compared to the general population, and considering that prostate cancer survivors make up the largest group of cancer survivors, it is imperative to develop a model for predicting suicide risk among prostate cancer survivors. Methods: Clinical data of prostate cancer patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database and randomly divided into a training cohort and a validation cohort in a 7:3 ratio. Initial variable selection was performed using univariate Cox regression, Best Subset Regression (BSR), and Least Absolute Shrinkage and Selection Operator (LASSO). Variables to be included in the final model were selected using backward stepwise Cox regression. Model performance was evaluated using the Concordance Index (C-index), Receiver Operating Characteristic (ROC) curves, and calibration curves. Results: Data from 238,534 prostate cancer patients were obtained from the SEER database, of which 370 (0.16%) died by suicide. Seven variables including age, race, marital status, household income, PSA levels, M stage, and surgical status were included in the final model. The model demonstrated good discriminative ability in both the training and validation cohorts, with C-indices of 0.702 and 0.688, respectively. ROC values at 3, 5, and 10 years were 0.727/0.644, 0.700/0.698, and 0.735/0.708, respectively. Calibration curves indicated a high degree of consistency between model predictions and actual outcomes. High-risk prostate cancer survivors had a 3.5 times higher risk of suicide than the low-risk group (0.007 vs. 0.002, P < 0.001), a finding supported by data from the validation cohort and the entire cohort. Conclusion: A reliable predictive model for suicide risk among prostate cancer survivors was successfully established based on seven readily obtainable clinical predictors. This model can effectively aid healthcare professionals in quickly identifying high-risk prostate cancer survivors and timely implementation of preventive interventions.

    Keywords: prostate cancer, suicide risk, nomogram, prevention, SEER

    Received: 19 Aug 2024; Accepted: 20 Mar 2025.

    Copyright: © 2025 Yang, Liu, Qu, jiang, Hao, Rong, Zheng and Ning. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    jie An Zheng, Baoji Gaoxin Hospital, Baoji, China
    Peng Ning, Baoji Gaoxin Hospital, Baoji, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    95% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more